With its stock down 38% over the past three months, it is easy to disregard Compumedics (ASX:CMP). It is possible that the markets have ignored the company's differing financials and decided to ...

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for Compumedics, this is the ...

Compumedics has displayed significant magnetoencephalography (MEG) recordings optimized for pediatrics from the system successfully installed at Tianjin Normal University (TJNU) in China. This ...

Compumedics (ASX:CMP) said the last financial year laid a stronger more scalable business model for FY26 and beyond with record sales orders of $63.4 million, up 22% on FY24. EBITDA increased to ~$3m, ...

Compumedics Limited (AU:CMP) has released an update. Compumedics Limited bolsters its U.S. presence with the appointment of Craig Gallivan as National Vice President of Sales for its Home Sleep ...

Compumedics Limited (AU:CMP) has released an update. Compumedics Limited projects a record-breaking year with over $50 million in sales orders and at least $46 million in revenue for FY24, driven by ...

Compumedics has received FDA approval to market Falcon, its second home sleep testing solution in the US, with potential to substantially boost its revenue. Don't miss out on the headlines from ...

Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. If the home-grown player in cognitive and sleep analysis achieves this, Compumedics will have completed ...

MELBOURNE, Australia--(BUSINESS WIRE)--Compumedics Limited (ASX: CMP), a world leading supplier of innovative medical technology for patient monitoring, has in collaboration with Beijing Fistar and ...

Compumedics achieves record revenue of $51 million and sales orders of $63.4 million in FY25 Company returns to profitability, with EBITDA of ~$3 million and sleep and neurology segment orders up 439% ...

Compumedics delivers breakout performance in FY25 with record revenue and sales orders, a return to profitability, and accelerating growth in the US and SaaS segments. Compumedics (ASX:CMP) said the ...